These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12428841)

  • 41. Latanoprost in the treatment of eyelash alopecia in alopecia areata universalis.
    Coronel-Pérez IM; Rodríguez-Rey EM; Camacho-Martínez FM
    J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):481-5. PubMed ID: 20028444
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Examining the relationship between alopecia areata, androgenetic alopecia, and emotional intelligence.
    Monselise A; Bar-On R; Chan L; Leibushor N; McElwee K; Shapiro J
    J Cutan Med Surg; 2013; 17(1):46-51. PubMed ID: 23364150
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Platelet-rich fibrin matrix (PRFM) for androgenetic alopecia.
    Sclafani AP
    Facial Plast Surg; 2014 Apr; 30(2):219-24. PubMed ID: 24810134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Androgenetic alopecia and current methods of treatment.
    Bienová M; Kucerová R; Fiurásková M; Hajdúch M; Koláŕ Z
    Acta Dermatovenerol Alp Pannonica Adriat; 2005 Mar; 14(1):5-8. PubMed ID: 15818439
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Topical adenosine increases thick hair ratio in Japanese men with androgenetic alopecia.
    Watanabe Y; Nagashima T; Hanzawa N; Ishino A; Nakazawa Y; Ogo M; Iwabuchi T; Tajima M
    Int J Cosmet Sci; 2015 Dec; 37(6):579-87. PubMed ID: 25925959
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of men and women's experiences of chemotherapy-induced alopecia.
    Can G; Demir M; Erol O; Aydiner A
    Eur J Oncol Nurs; 2013 Jun; 17(3):255-60. PubMed ID: 22901547
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A review of medical and surgical treatment options for androgenetic alopecia.
    Rousso DE; Kim SW
    JAMA Facial Plast Surg; 2014; 16(6):444-50. PubMed ID: 25188680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic experience with oral finasteride for androgenetic alopecia in female-to-male transgender patients.
    Moreno-Arrones OM; Becerra A; Vano-Galvan S
    Clin Exp Dermatol; 2017 Oct; 42(7):743-748. PubMed ID: 28691187
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The prevalence and types of androgenetic alopecia in Korean men and women.
    Paik JH; Yoon JB; Sim WY; Kim BS; Kim NI
    Br J Dermatol; 2001 Jul; 145(1):95-9. PubMed ID: 11453914
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomized Placebo-Controlled, Double-Blind, Half-Head Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia.
    Alves R; Grimalt R
    Dermatol Surg; 2016 Apr; 42(4):491-7. PubMed ID: 27035501
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stem cell therapy as a novel therapeutic intervention for resistant cases of alopecia areata and androgenetic alopecia.
    Elmaadawi IH; Mohamed BM; Ibrahim ZAS; Abdou SM; El Attar YA; Youssef A; Shamloula MM; Taha A; Metwally HG; El Afandy MM; Salem ML
    J Dermatolog Treat; 2018 Aug; 29(5):431-440. PubMed ID: 27553744
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of long-term efficacy of finasteride in Korean men with androgenetic alopecia using the basic and specific classification system.
    Shin JW; Chung EH; Kim MB; Kim TO; Kim WI; Huh CH
    J Dermatol; 2019 Feb; 46(2):139-143. PubMed ID: 30536893
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation and diagnosis of the hair loss patient: part I. History and clinical examination.
    Mubki T; Rudnicka L; Olszewska M; Shapiro J
    J Am Acad Dermatol; 2014 Sep; 71(3):415.e1-415.e15. PubMed ID: 25128118
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dermoscopic findings in scalp psoriasis and seborrheic dermatitis; two new signs; signet ring vessel and hidden hair.
    Kibar M; Aktan Ş; Bilgin M
    Indian J Dermatol; 2015; 60(1):41-5. PubMed ID: 25657395
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence and types of androgenetic alopecia in north Anatolian population: A community-based study.
    Bas Y; Seckin HY; Kalkan G; Takci Z; Citil R; Önder Y; Sahin S; Demir AK
    J Pak Med Assoc; 2015 Aug; 65(8):806-9. PubMed ID: 26228320
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distinguishing androgenetic alopecia from chronic telogen effluvium when associated in the same patient: a simple noninvasive method.
    Rebora A; Guarrera M; Baldari M; Vecchio F
    Arch Dermatol; 2005 Oct; 141(10):1243-5. PubMed ID: 16230561
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Androgenetic alopecia and coronary artery disease in women.
    Mansouri P; Mortazavi M; Eslami M; Mazinani M
    Dermatol Online J; 2005 Dec; 11(3):2. PubMed ID: 16409898
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Androgenetic alopecia in women as an aesthetic and psychological problem].
    Kazimierczak M; Bielecka-Grzela S; Klimowicz A
    Ann Acad Med Stetin; 2008; 54(3):126-9. PubMed ID: 19839524
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patient-perceived importance of negative effects of androgenetic alopecia in women.
    Girman CJ; Hartmaier S; Roberts J; Bergfeld W; Waldstreicher J
    J Womens Health Gend Based Med; 1999 Oct; 8(8):1091-5. PubMed ID: 10565667
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
    Olsen EA; Dunlap FE; Funicella T; Koperski JA; Swinehart JM; Tschen EH; Trancik RJ
    J Am Acad Dermatol; 2002 Sep; 47(3):377-85. PubMed ID: 12196747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.